Back to search
FDAFDA · Food and drugs·Recall number D-1060-2014

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75mg/0.2mg, Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60 (60 count bottles)

Published February 12, 2014 · Recall initiated: March 22, 2013

Summary

FDA records drug Class II recall D-1060-2014, published February 12, 2014 and initiated March 22, 2013. Recalling firm: Actavis Inc; Status: Terminated; Reported quantity: 6,540 bottles; Lot: Lot 668271A, Exp 11/14 and Lot 684119A Exp 01/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Broken tablets

What to do

Voluntary: Firm initiated · Letter

Get an email if DICLOFENAC SODIUM AND MISOPROSTOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DICLOFENAC SODIUM AND MISOPROSTOL
Manufacturer
Actavis Inc
Distributor
Nationwide
Lot
Lot 668271A, Exp 11/14 and Lot 684119A Exp 01/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75mg/0.2mg, Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60 (60 count bottles) recalled?

Yes. FDA published recall D-1060-2014 on February 12, 2014. Reported hazard: Failed Tablet/Capsule Specifications: Broken tablets

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DICLOFENAC SODIUM AND MISOPROSTOL.